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Aim: Previous study findings have shown that more frequent contacts with the diabetes care
team predict better diabetes control. It is unknown whether this is true also for previous
dropouts with type 2 diabetes (T2D). The aim of this study was to evaluate if those previous
dropouts with T2D who succeeded to improve their glycaemic control had more frequent
contacts with health care professionals in the public primary diabetes health care system
than  those dropouts who did not show improvement.
Methods: In this “real life” retrospective cohort study, we identified 115 dropouts with T2D
who  were contacted by trained diabetes nurses and who returned to a public T2D-care
system. Those previous dropouts who had baseline haemoglobin A1c ≥53 mmol/mol (7%)
and had a reduction in HbA1c ≥ 6 mmol/mol (0.5%) during the follow-up were compared
with those with unsatisfactory change in HbA1c (baseline HbA1c ≥ 53 mmol/mol and change
<6  mmol/mol, or HbA1c < 53 mmol/mol at the baseline measurement but above that in the
end  of the study period) or with those who remained at good glycaemic control over the
study period. Trained diabetes nurses collected quantitative data from the patient records
about visits and contacts during the follow-up.Please cite this article in press as: T. Kauppila, et al., Relationship between number of contacts between previous dropouts with type
2 diabetes and health care professionals on glycaemic control: A cohort study in public primary health care, Prim. Care Diab. (2019),
https://doi.org/10.1016/j.pcd.2019.03.003
Results: Previous dropouts showing improvement had more visits to the diabetes nurse
(p  = 0.003) and other nurses (p < 0.001) than those with no improvement or those with sat-
isfactory glycaemic control. Telephone calls not focusing on diabetes (p < 0.001) were also
more  frequent among previous dropouts with improvement than among the others.
Conclusions: Especially previous dropouts with T2D who had poor glycaemic control, may
benefit from more frequent contacts including visits and telephone calls. Recalling dropouts
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does not seem to lead to overuse of the T2D care-system by those recalled patients whose
glycaemic control does not require special care.
©  2019 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.1.  Introduction
Type 2 diabetes (T2D) is a major health burden globally [1]. It
has been estimated that one in 11 adults has diabetes [1]. The
general treatment goal of diabetes is to prevent acute compli-
cations, reduce the risk of long-term complications including
macro- and micro-vascular complications, and ensure an opti-
mal  quality of life [2–4].
An optimal treatment of diabetes consists of both lifestyle
modifications and drug treatment [2–4]. Treatment efficacy
evaluation is based on patients’ subjective well-being, phys-
ical assessments and laboratory tests performed by health
care professionals. A proportion of patients with T2D does not
attend diabetes clinics as prescribed by the health care per-
sonnel. These dropouts may be exposed to a notable risk for
diabetic complications thus reducing their quality of life and
raising the costs of diabetes treatment.
In the public primary health care centre of the city of
Vantaa, Finland, we  carried out a study focusing upon the phe-
nomenon of dropout. According to our study findings, one in
ten patients with T2D was a dropout from the public primary
diabetes health care system [5]. Further, the dropouts with
T2D were difficult to bring back to the system [6]. Those who
had poor glycaemic control and were successfully re-attached
to the diabetes treatment system (e.g. previous dropouts)
seemed to benefit from recalling [6].
Recalling T2D dropouts is not necessary without problems.
First, although there are former studies suggesting that more
frequent contacts with the diabetes care centres predict bet-
ter diabetes control [7–10] it is not known whether this is true
also among the previous dropouts with T2D. Further, we do
not know whether this intervention leads to increased use
of the T2D care system by those patients gaining the most
from it. Second, increased supply of care may lead to a situ-
ation where those patients whose clinical condition does not
require enhanced treatment find this service and start to use
the care system more  than their clinical status would require.
This has been shown to happen in various clinical settings
[11–13]. We  do not know if there is a risk of overuse of T2D
care system among previous dropouts.
The aim of this “real life”-study was to evaluate if the num-
ber of contacts with health care professionals in the public
primary diabetes health care system among previous dropouts
with T2D was associated with improved glycaemic control
after their return to the system.
2.  Methods
2.1.  Design  and  settingPlease cite this article in press as: T. Kauppila, et al., Relationship be
2 diabetes and health care professionals on glycaemic control: A coh
https://doi.org/10.1016/j.pcd.2019.03.003
This study is an observational retrospective register-based
cohort study using data obtained from an electronic patientrecord system. In 2009, a project for improving the glycaemic
control in people with T2D in the primary health care in
the city of Vantaa, Finland was initiated. The ethics com-
mittee of the Hospital District of Helsinki and Uusimaa (Nr
91/13/03/01/2011, 9.1.2013) and health authority of the Vantaa
city (Dno SOSTER 3124/2011/092) approved the study. Accord-
ing to the ethics committee of the Hospital District of Helsinki
and Uusimaa, and health authority of the Vantaa city the study
participants do not need to sign a Statement of Informed Con-
sent because the study was retrospective, based on patient
charts and the investigators did not contact the dropouts.
In Finland, primary care and especially treatment of T2D is
mostly run by the public system and funded with taxes. T2D
care is mostly provided by general practitioners (GPs) and, in
more severe cases, by GPs specialized in diabetes treatment. If
the patient has severe T2D complications he or she is referred
to a specialist in the secondary care but the GP still follows the
treatment and takes the overall responsibility of the treatment
during stable phases. Finnish primary care follows the present
guidelines of T2D treatment and in uncomplicated cases with
good glycaemic control the patient is supposed to visit labo-
ratory and meet his or her GP at least once in the year [2,4].
If the glycaemic control or clinical status requires more  fre-
quent controls they are arranged according to international
recommendations: regular and frequent visits, e.g. every three
months, and evaluation of the therapy until stable glycaemic
control is achieved [2,4].
This retrospective observational cohort study was per-
formed based upon clinical data obtained from the public
primary health care of the eastern districts of the City of Van-
taa. At the time of the study, Vantaa had a population of 195 397
inhabitants and in the eastern districts there were 118 802
inhabitants. We identified all patients aged 18–80 years who
had an International Statistical Classification of Diseases and
Related Health Problems 10th Revision (ICD-10) code contain-
ing an E11 code in the patient charts or who  were prescribed
specific anti-hyperglycemic drugs for T2D from 1-January-
2005 to 31-December-2009. In Finland, the primary health
care used ICD-10 codes to classify diseases, health related
disorders, injuries, infections, and symptoms. A computer-
based search was made from Finstar (Logica, Helsinki, Finland)
patient chart system with a specific report generator.
Patients who fulfilled the described T2D criteria but had
not contacted the public health care system during the past 12
months (year 2009) were entered into the data base; altogether
about one in ten of patients with T2D. To detect whether these
patients were true dropouts or whether they were receiving
treatment elsewhere (e.g. having the treatment arranged in
another system, private or secondary care), the nurses of the
public health care system contacted them by phone. In order totween number of contacts between previous dropouts with type
ort study in public primary health care, Prim. Care Diab. (2019),
improve diabetes treatment of all these putative dropouts and
to bring them back to the public primary diabetes care system
a trained diabetes nurse contacted these persons. We recorded
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Table 1 – Characteristics of the study population (N = 115).
Study subjects p-Value Study subjects, all N = 115
Males Females
Gender, percentage (n) 53.9 (62) 46.1 (53) 0.099
Age, years 64.0 (56.8–68.3) 61.0 (53.5–68.0) 0.210 61.4 (9.4)
Duration of diabetes, years 7.0 (3.5–10.0) 4.5 (2.0–9.0) 0.040 6.7 (5.0)
Baseline HbA1c (mmol/mol) 50.0 (42.8–60) 46.0 (40.5–63.5) 0.678 55 (20)
Body mass index (kg/m2) 30.3  (27.7–33.4) 33.5 (30.2–35.9) 0.050 31.9 (7.0)
LDL-cholesterol (mmol/l) 2.59 (0.84) 3.07 (0.94) 0.006 2.81 (0.91)
Diabetes visits to physician, n 1.0 (1.0–2.0) 1.0 (0.0–2.0) 0.127 1.2 (1.1)
Other visits to physician, n 3.0 (2.0–5.0) 3.0 (1.50–6.0) 0.863 4.0 (5.0
Visits to diabetes nurse, n 4.0 (2.0–5.8) 4.0 (2.0–7.0) 0.365 3.2 (2.4)
Visits to unspecialized nurse, n 3.0 (2.0–4.0) 2.5 (1.0–5.0) 0.607 3.4 (2.5)
Diabetes-related telephone calls, n 2.0 (1.0–3.5) 3.0 (1.0–5.5) 0.207 3.7 (3.8)
Not diabetes-related telephone calls, n 5.0 (2.0–9.0) 4.00 (2.3–8.0) 0.837 6.6 (6.3)
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fterwards the effects of the work performed by the commu-
ity primary health care nurses and general practitioners [5].
At the baseline visit the participant’s status was assessed,
aboratory tests were taken, diabetes counselling was given
nd treatment was enhanced when needed [5]. The “sec-
nd follow-up” visit was the closest visit more  than one year
fter the first visit (13–30 months after the baseline visit) and
ncluded the same assessments as the baseline visit. At the
second follow-up” visit haemoglobin A1c (HbA1c) levels were
ssessed to detect the success of treatment. Of the dropouts,
bout one third (n = 115) remained in the study [6]. These previ-
us dropouts composed the study cohort of the present study.
The recalled dropouts were divided into three groups
ccording to their glycaemic control at the baseline visit
nd at the follow-up visit. Group 1 consisted of those pre-
ious dropouts who had a HbA1c level ≥ 53 mmol/mol (7%)
t the baseline visit and a reduction in HbA1c ≥ 6 mmol/mol
0.5%) during the follow-up time. They were defined as
revious dropouts with improvement in glycaemic control.
roup 2 consisted of those dropouts who had a HbA1c
evel ≥ 53 mmol/mol (7%) at the baseline visit and the decrease
f HbA1c level was <6 mmol/l (0.5%) or those dropouts who
ad a HbA1c level < 53 mmol/mol (7%) at the baseline visit but
ore than that after the follow-up visit. They were defined as
revious dropouts without improvement. Group 3 consisted of
hose dropouts who  had a HbA1c level < 53 mmol/mol (7%) and
he HbA1c level remained under this value during the follow-
p time. They were defined as previous dropouts with good
lycaemic control.
According to international guidelines and epidemiologic
tudies [2,4] diabetic complications increase significantly if
evel of HbA1c is >53 mmol/mol (7%) this level was chosen as
n indicator of good glycaemic control. The level of change in
bA1c (6 mmol/mol, 0.5%) was chosen because previous stud-
es have shown that reducing HbA1c by this amount reduces
ncidence of complications in T2D [14,15].Please cite this article in press as: T. Kauppila, et al., Relationship be
2 diabetes and health care professionals on glycaemic control: A coh
https://doi.org/10.1016/j.pcd.2019.03.003
.2.  Primary  outcomes
rained diabetes nurses collected data from the patient
ecords on number of diabetes and non-diabetes related visitst-test or median (interquartile range 25%–75%) and p-values as
to physicians, number of visits to diabetes nurses, number of
visits to unspecialized nurses, number of diabetes and non-
diabetes related telephones calls.
2.3.  Statistical  analysis
Data are reported as percentage (n) or mean (standard devi-
ation, SD) or median (interquartile range, IQR 25%–75%).
Percentage differences were tested using cross-tabulation and
Chi-Square test. Comparisons were carried out with t-test,
Mann–Whitney U-test parametric, or non-parametric ANOVA
(Kurskall–Wallis) followed by Dunn’s post-hoc test between
the groups. Statistical analyses were carried out using IBM
SPSS, version 23.0 (IBM, Armonk, NY, USA). A P-value of less
than 0.05 was considered statistically significant.
3.  Results
Duration of diabetes was significantly longer among men
than among women. Of the study subjects, 60.9% had
HbA1c < 53 mmol/mol (7.0%). No significant differences were
observed in age between men  and women, neither in number
of visits to physicians, nurses or in telephone contacts. Body
mass index and LDL-cholesterol concentrations were higher in
women than in men. The baseline characteristics of the study
subjects are shown in Table 1.
Baseline BMI was higher in dropouts with improvement
than in the other groups. (Table 2). Previous dropouts with
improvement were significantly younger than those without
improvement. Previous dropouts with improvement had more
visits to physicians and especially more  visits to nurses focus-
ing on diabetes than those without improvement. Number of
telephone calls were more  frequent among previous dropouts
with improvement than among those without improvement;
telephone calls focusing on diabetes and, telephone calls not
focusing on diabetes, respectively. Duration of T2D was longertween number of contacts between previous dropouts with type
ort study in public primary health care, Prim. Care Diab. (2019),
among those without improvement than those with good gly-
caemic control. There was no difference in the distribution of
males and females into the improvement, no improvement or
good control groups (p = 0.715, Chi-Square).
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Table 2 – Characteristics and numbers of contacts to the health care professionals among study subjects witha and
without improvementsb in glycaemic control and among the study subjects with good glycaemic control.
Group 1 Group 2 Group 3 p-Value (ANOVA)
Subjects with
improvementa
Subjects without
improvementb
Subjects with
good glycaemic
control
n = 36 n = 27 n = 52
Male/female, number 20/16 16/11 26/26
Age, years 56.5 (52.3–64.8)**.# 67.0 (55–70) 64.5 (59.0–69.0) 0.003
Duration of diabetes, years 6.5 (3.3–10.0) 10.0 (6.0–10.0)*** 4.0 (2.0–8.0) <0.001
Baseline HbA1c, mmol/mol 71.5 (52.8–94.3)*** 54.0 (50.0–61.0)*** 41.0 (39.0–44.0) <0.001
Diabetes visits to physician, n 2.0 (1.0–2.0)* 1.0 (0.0–2.0) 1.0 (0.0–1.0) 0.009
Not diabetes-related visits to physician, n 3.0 (2.0–5.0) 3.0 (2.0–5.0) 3.0 (2.0–5.5) 0.964
Visits to diabetes nurse, n 6.0 (4.0–8.0)*.## 3.0 (2.0–6.0) 3.0 (2.5–5.0) 0.003
Visits to unspecialized nurse, n 4.0 (2.0–7.0) **.# 2.0 (1.0–4.0) 2.0 (1.0–3.0) <0.001
Diabetes-related telephone calls, n 4.0 (1.5–7.5)** 2.0 (1.0–9.0) 2.0 (1.0–2.0) 0.009
Not diabetes-related telephone calls, n 7.0 (5.0–12.5)***.# 3.5 (1.0–12.0) 3.5 (2.0–6.0) <0.001
LDL-cholesterol at baseline visit, mmol/L 2.8 (2.2–3.4) 2.8 (2.2–3.3) 2.6 (2.0–3.4) 0.788
Systolic blood pressure at baseline visit, mmHg 141 (19) 145 (26) 145 (21) 0.708
Diastolic blood pressure at baseline visit, mmHg 84 (11) 85 (10) 84  (10) 0.909
Body mass index, kg/m2 33.6 (30.6–38.0)*.# 30.1 (26.7–32.9) 31.0 (26.9–34.8) 0.015
Results are presented as mean (standard deviation) and p-values as t-test or median (interquartile range 25%–75%) and p-values as
Mann–Whitney U-test unless otherwise mentioned.
*p < 0.05, **p < 0.01, ***p < 0.001 vs. subjects with good glycaemic control, Dunn’s post-hoc-test.
#p < 0.05, ##p < 0.01 vs. subjects without improvement, Dunn’s post-hoc- test.
a With improvement: HbA1c level ≥ 53 mmol/mol (7%) at the baseline visit and a reduction in HbA1c ≥ 6 mmol/mol (0.5%) during the follow-up
time.
line 
 visitb Without improvement: HbA1c level ≥ 53 mmol/mol (7%) at the base
dropouts who had a HbA1c level < 53 mmol/mol (7%) at the baseline
4.  Discussion
Previous T2D dropouts with significant improvement in their
glycaemic control seemed to have more  frequent visits or
telephone contacts focusing on diabetes with health care pro-
fessionals than those who did not show improvement in their
glycaemic control. This was seen in all studied parameters
but especially in contacts with nurses. Those who had impair-
ment in their level of treatment did not show increase levels
of contacts concerning diabetes when compared with pre-
vious dropouts doing well. Our study observations suggest
that previous dropouts with T2D in non-optimal glycaemic
control may benefit from frequent contacts with health care
professionals. Yet, if T2D had lasted long it seemed difficult
for dropouts to improve glycaemic control. Those previous
dropouts with satisfactory glycaemic control do not need a
high frequency of contacts focusing on diabetes and, in line
with that, they did not seem to use the health care system
excessively.
Previous studies focusing on the phenomenon of dropouts
with T2D have concentrated mainly on prevention of relapses
and/or on description of the dropouts [5,16–19]. Although T2D
is significant in view of public health [20] studies concerning
how previous dropouts from T2D care use health services do
not exist. According to our previous study findings from this
same study cohort, these dropouts are challenging to bring
back to the health care system; even when trained diabetesPlease cite this article in press as: T. Kauppila, et al., Relationship be
2 diabetes and health care professionals on glycaemic control: A coh
https://doi.org/10.1016/j.pcd.2019.03.003
nurses contacted them personally, only one third were re-
attached [6]. To the best of our knowledge, studies focusing
upon the importance of number of contacts between pre-visit and the decrease of HbA1c level was <6 mmol/l (0.5%) or those
 but more than that after the follow-up visit.
vious dropouts and health care professionals in relation to
glycaemic control are missing.
Among patients with unsatisfactory glycaemic control,
an association between visit frequency and better diabetes
control has been shown in several studies [7–10]. According
to a U.S. study, patients with T2D with relatively poor gly-
caemic control showed significant and clinically meaningful
improvements in HbA1c when contacted weekly by members
of the health care system [7]. Our study observations endorse
the U.S. study findings: those previous dropouts with T2D
who achieved an improvement in haemoglobin defined as
A1c ≥ 6 mmol/mol (0.5%) had typically non-optimal glycaemic
control at baseline. During the follow-up they had 50% more
frequent diabetes focused visits or telephone contacts with
health care professionals than those without improvement.
The international diabetes guidelines recommend regular and
frequent visits, e.g. every three months, and evaluation of the
therapy until stable glycaemic control is achieved [2,4]. These
recommendations about check-up rates are well in line with
what we  observed in the previous T2D dropouts with good
glycaemic control.
The present intervention seemed to be beneficial
for the patients with non-optimal glycaemic control
(HbA1c > 53 mmol/mol [7%]). Those patients who  did not
improve their glycaemic control had already satisfactory or
good glycaemic control and thus, there was no need for more
frequent contacts. Those patients whose glycaemic control
was poor and who did not improve or those patients whosetween number of contacts between previous dropouts with type
ort study in public primary health care, Prim. Care Diab. (2019),
control was good at baseline but unsatisfactory in the end did
not differ from the dropouts who were doing well already at
baseline in any of the studied parameters.
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Among the dropouts, the reasons for poor glycaemic con-
rol are multiple. Patient with chronic diseases including
iabetes, are reported to have poor medication adherence,
hich is certainly one continuing problem for health care
roviders [21]. There are various underlying factors for poor
dherence such as patient related factors (e.g. remembering
o take medications, health beliefs), medication related factors
e.g. complexity, cost, side effects) and system related factors
e.g. inadequate follow-up or support) [4].
Every effort to improve glycaemic control and well-being
n T2D patients is important in order to reduce diabetic com-
lications [12]. According to our present and previous data [8],
ll health care professionals have the opportunity to influence
he situation, even in case of dropouts with T2D.
This study material was extracted from patient records.
he contact related data is complete and contains all the
ropouts from public T2D care system. However, to comply
ith ethical permission we were only able to use retrospective
eal-life information from the patient charts to get infor-
ation about the previous dropouts. Personal contacts and
urther interviews were not possible. No more  detailed infor-
ation was therefore available. The present study describes
nly behaviour of dropouts from the public primary care dia-
etes treatment system. Data on dropouts’ lifestyle factors,
ncluding physical activity, dietary or sleeping habits, smok-
ng and alcohol consumption, as well as other medications
han diabetes medications were not available. These factors
ay influence the results and should be addressed in future
tudies. Further, almost all our participants were of Cau-
asian ancestry, which may influence the generalizability of
he results.
.  Conclusions
fforts for improving glycaemic control in patients with T2D
nd with poor glycaemic control are worth performing, also
mong dropouts with T2D. To ensure contacts between the
atients and the health care system seems to be essential for
uccess. When recalling dropouts with T2D, it is worth to allo-
ate resources to the patients with worst glycaemic control.
Especially previous dropouts with T2D who had poor gly-
aemic control, may benefit from frequent controls by visits
nd telephone calls when improving their glycaemic control.
hose previous T2D dropouts who have appropriate glycaemic
ontrol do not seem to induce an inappropriate work load to
he health care system.
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